Ignite Creation Date:
2025-12-24 @ 2:09 PM
Ignite Modification Date:
2025-12-27 @ 9:58 PM
Study NCT ID:
NCT01582295
Status:
COMPLETED
Last Update Posted:
2017-05-25
First Post:
2012-04-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
XL184 For Relapsed/Refractory Multiple Myeloma (MM) With Bone Disease
Sponsor:
Massachusetts General Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
12-005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None